JW Therapeutics’ Carteyva Receives NMPA Approval for Moderate-to-Severe SLE Clinical Trial
China-based JW Therapeutics (HKG: 2126) has announced receiving tacit clinical trial approval from the National...
China-based JW Therapeutics (HKG: 2126) has announced receiving tacit clinical trial approval from the National...
China-based Hua Medicine (HKG: 2552) has announced a sales and distribution agreement with online pharma...
China-based CStone Pharmaceuticals (HKG: 2616) has announced a lower recommended price for its precision medicine...
China-based Hangzhou Baikai Biomedical Co., Ltd and Leads Biolabs Inc. have announced a partnership aimed...
The National Health Commission (NHC) has released the “Report on the National Monitoring and Analysis...
Researchers from Cuba and China at the Yongzhou joint biotechnology innovation center in China’s Hunan...
The Hebei medical drug and device centralized procurement center has announced the start of the...
The Center for Drug Evaluation (CDE) website has indicated that Takeda Pharma’s (TYO: 4502) Iclusig...
China-based ophthalmology specialist Arctic Vision has entered into a strategic partnership with Sinopharm Group Distribution...
According to an analysis, the US FDA issued complete response letters (CRLs) to six novel...
Bioyond Robotics, a Shanghai-based intelligent automation company, has reportedly raised around RMB 200 million (USD...
The Henan Province Public Resources Trading Center has released a notification regarding the completion of...
China-based cell therapy-focused Contract Development and Manufacturing Organization (CDMO) Jiangsu Hillgene Biopharma Co., Ltd has...
Maryland-based Contract Development and Manufacturing Organization (CDMO) Forecyte Biotechnologies has announced the opening of a...
China-based Yiling Pharmaceutical Co., Ltd (SHE: 002603) has announced its plans to initiate a Phase...
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE: 002223), a China-based medical device company,...
Sino-US firm MicuRx Pharmaceuticals Inc. has announced the initiation of a Phase III clinical study...
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) has announced a partnership with China’s Guangzhou Institute...
Indonesia’s deputy minister of health, Dante Saksono Harbuwono, visited China last week as part of...
In preparation for a volume-based procurement (VBP) round, Shanxi province has initiated the gathering of...